SUMMARY:
In 1975, M. Chateau 16 , wrote that only a first stage of treatment, by rigid bimaxillary hyperpropulsion, could correct mandibular retrognathism.
Since then, we have witnessed a double paradigm shift.
The first has seen the replacement of traditional sources of information, and their limitations, by access to the best published data, using an evidence-based approach. It has shed light on the debate about the treatment of Class-II malocclusions in children and adolescents, particularly on one-phase or two-phase treatments. Can a two-phase treatment increase the amount of mandibular growth in the long term? Can it increase the volume of the airways? Can it help prevent maxillary incisor trauma or root resorptions? The second paradigm shift concerns the treatment of Class-II malocclusions in children and adolescents. To discover that the long-term skeletal effects of an initial phase of treatment are weak and clinically insignificant at best has been a bitter disappointment for our profession. But this new data also led to developments in treatment. The treatment of mandibular retrognathism has given way to an effective correction of Class-II malocclusions, which best suits the particular case of the patient, child, or adolescent.
was published, was mandibular retrognathism.
Mr. Chateau 15 , who found a confirmation of his ideas in the work of Pétro-vic 53, 55 , stated that "only bimaxillary, removable, and non-elastic hyperpulsive devices are convenient and effective for causing hyperactivity of propulsive muscles and activating mandibular growth in an anterior direction.
The treatment of a Class-II malocclusion with mandibular retrognathism therefore requires rigid bimaxillary hyperpropulsion as the first phase of treatment.
What is the situation today? Authors' opinions and published data, for example from the article by M. Château and Y. Le Gall 16 , are often contradictory. The relative lack of publications in the past and present can probably be explained to a large extent by the fact that the proposed therapeutic options work sufficiently well and often enough to allow for their subsequent use. So far, none of treatment options have been decisively demonstrated to be effective, which leads to doubts about the clear superiority of one of them.
Therefore, on what elements can clinicians rely on, to propose a treatment plan to his patient, which is not only effective but also the most appropriate for their individual case?
The paradigm shift in clinical decision making Clinical decision making is by nature the core of the line of work of orthodontists and its most medical aspect 5 . The medical history, the clinical examination, and the supplementary examinations are the sources of information needed to reach a diagnosis. Where can we find other information needed for clinical decision making?
In the 1970s, only traditional sources of information were available, all of which had their own limitations: -The contents of the clinical manuals could be quickly rendered obsolete; -Authors ' opinions may not have been validated scientifically; -Clinical cases seen or read, could not account for the diversity of clinical solutions published in specialized journals; -The scientific press was less easily accessible, because of a lack of electronic resources (access to e-databases and online journals); -The methodological quality of the studies was inferior, and there were no systematic reviews of the literature.
Since the publication of the article by M. Château et Y. Le Gall 16 , a paradigm shift has occurred, thanks to the access to the best published data, using the evidence-based approach 4, 61 . The use of evidence-based orthodontics (EBO) (Fig. 1) is easy, particularly in the user mode 3 , with the search for the best pre-evaluated data by means of the "6S" pyramid 23, 29 (Fig. 2) . Among the incessant flow of scientific publications, the EBO helps us to quickly search and evaluate the methodological quality, select the best available information, combine them with our individual clinical competence, and thus deliver more effective care while taking into account the needs and the situation of our patients.
It has become essential and has helped to illuminate the debate around the treatment of Class-II malocclusions in children and adolescents, particularly with one-phase or two-phase treatments. Explaining how to assess the validity of the various current aspects of clinical decision making for the treatment of Class-II malocclusions in children and adolescents is inconsistent with the limited scope of an article. We will limit our talk to four questions for which the EBO helps to provide answers when making an informed choice of a therapeutic option for our patients.
Can two-phase treatment increase the amount of mandibular growth in the long run?
Since 1879, and the birth of functional treatments with Kingsley, which introduced the expression "Jumping the bite" and recommended treating mandibular retrognathism with forced mandibular propulsion, countless types of functional devices, and therapeutic modalities have been proposed. Although many publications 18, 43, 69 have reported mandibular extension higher than those of untreated subjects after a functional treatment phase without the respective contributions, the treatment has been applied and favorable growth has been clearly established.
On the other hand, long-term studies on the treatment of Class-II malocclusions showed that if mandibular growth could be greater than that of untreated subjects during the functional treatment phase, it then declined. Only the rate of growth, not its quantity, seems to be modified 22, 46 ( Fig. 3a and b, Fig. 4a-d, Fig. 5a and b, Fig. 6a-c,  Fig. 7a-c, Fig. 8a-c, Fig. 9a and b) .
The recent Cochrane systematic review "Orthodontic treatment of prominent anterior maxillary teeth in children" 66 rules out long-term effects on mandibular growth.
The results of the last two systematic reviews 20, 52 , published on this topic, indicate that the long-term skeletal effects of a first phase of treatment are weak and clinically insignificant at best.
Can a two-phase treatment increase the volume of the airways?
The prevalence of sleep ventilatory disorders was estimated to be 6% among adolescents, and these disorders are associated with increase in excessive daytime sleepiness, difficulties in learning in school, and the onset of attention deficit hyperactivity disorder (ADhD) 33 . Mandibular retrognathism was identified as one of the predisposing factors of SVD 37 . It is associated with a constriction of the oropharyngeal pathways, which could be explained by a more pronounced position of the tongue base and the hyoid bone. 25, 48 a b Clinical studies show that functional device therapy increases the volume of the oropharyngeal pathways and the anteroposterior position of the hyoid bone, and helps patients with Class-II malocclusions 32, 58, 68, 70 . (Fig. 10a and b,  Fig. 11, Fig. 12 ).
If these results seem to be interesting, can it be said that they could contribute to the treatment of patients suffering from obstructive sleep apnea (OSA) syndrome? A recent systematic review is weakly affirmative 30 . The last Cochrane systematic review 14 , which represents the highest level of evidence currently available on this issue, was unable to conclude on the effectiveness or inefficiency of the use of functional devices for the treatment of OSA in children.
Does a two-phase treatment help to prevent trauma to the axillary incisors?
In children and adolescents, dental trauma represents an important public health problem, with a prevalence of 15%-30%, and, if untreated, they are responsible for a deterioration of the patient's quality of life 
Figure 12 Profile teleradiography after the first treatment phase, by quad-helix and a
Class-II corrector 6 . Note the anterior increase in the retrobasilingual space, partially related to the cephalic recovery observed on this teleradiography.
the frequency of incisor trauma, the increase of incisor overhang, and labial incompetence 13, 49 . Their conclusions have since been strengthened by the publication of a systematic review and meta-analysis, devoted to the association between dental trauma and increased incisor overhang 56 . Its results show a double risk of trauma to the maxillary incisors, whose overhang is greater than 3-4 mm, among subjects.
It may therefore seem relevant to want to prevent the trauma of the maxillary incisors by a first phase of early treatment, which is confirmed by the Cochrane systematic review "Orthodontic treatment of prominent anterior maxillary teeth in children" 66 . The authors conclude a significant decrease in the prevalence of incisor trauma, when the correction of an increased incisor overhang is obtained by a first phase of treatment in the child, compared to a treatment conducted in a single phase in early adolescence.
In particular, when the first phase of treatment was using functional devices ( Fig. 13a- Fig. 19 ), the odds ratio was 0.59, with a confidence interval of 0.35-0.99, which means that in the group of children treated early on by functional devices, the risk of trauma was 41% lower than that of patients treated in a single phase of treatment in adolescence.
Does a two-phase treatment help prevent root resorption?
The Cochrane systematic review on "Orthodontic treatment of prominent anterior maxillary teeth in children" 66 concludes that, apart from the decrease in the prevalence of incisor trauma, there are no advantages to conducting treatment in two phases compared to a single-phase treatment in early adolescence.
This conclusion may surprise clinicians because of the positive correlations between the prevalence and severity of root resorptions, the importance of incisor apex displacement, and the duration of this displacement 26, 41, 67 . A retrospective study 11 , certainly of lesser methodological value than the Cochrane systematic review 66 , compared the prevalence of incisor root The results of this study are particularly enlightening. A prevalence of EARR of 5% or 11% was observed in children treated in two phases, with a first phase conducted, respectively, by functional device or extraoral force. The treated patients, in a single phase with a multiattachment treatment, showed a prevalence of EARR of 20%, which is 2-4 times higher.
An explanation, proposed by the authors, would be that in children who have benefited from a first phase of early treatment, the incisor overhang corrected with a multiattachment device was less significant. It should be noted that the current absence of evidence, to which the Cochrane systematic review 66 concludes, does not mean definitive evidence of absence. Clinicians can simply explain this to their patient and their family, make them benefit from their individual clinical competence and advise them of a first phase of treatment in case of increased incisor overhang ( Fig. 20a and b, Fig. 21a-d,  Fig. 22, Fig. 23a-d, Fig. 24a and b, Fig.  25 ), especially because marked risk factors of EARR are present. This mode of operation is precisely that of clinical decision making with the evidence-based orthodontics (EBO) 2, 4 . The paradigm shift in clinical decision making, when taking into account the results of the best published data, has as a practical consequence, a paradigm shift in the treatment of Class-II malocclusions in children and teenagers.
Abandonment of treatment of mandibular retrognathism by functional device
Most patients with Class-II malocclusions exhibit mandibular retrognathism, rather than maxillary prognathism 44, 47 . It seems medically relevant to target our therapeutic action on the precise cause of the dysmorphisms, and therefore to favor the reduction of the mandibular retrognathism. If the correction of a molar Class-II malocclusion and an incisor overhang does not pose any particular difficulties 46 (Case no. 1 of Fig. 3-9) , the correction of a mandibular retrognathism appears to be a more ambitious objective. Can it be achieved, with what device and therapeutic sequence? These questions are at the heart of a controversy that still exists in our profession. The debate started in 1879, which saw the birth of functional treatments with Kingsley. At the beginning of the last century, Pierre Robin 59 advocated clearing the vital crossroads by wearing a monobloc. This device achieves a transverse expansion of the arches and maintains the mandible and tongue in an advanced position. Its indication is the treatment of glossoptosis, a condition where mandibular retrognathism is just one of the symptoms.
In 1946, Brodie 12 affirmed the genetic predetermination of irradiated and proportionate facial growth, according
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Figure 25
Profile teleradiography, at the end of the first phase of two-phase treatment.
to a facial pattern. Orthodontic treatment cannot alter skeletal disharmony persists, without improving or worsening. Orthodontic treatments correct Class-II malocclusions only using dentoalveolar compensation, and have no skeletal effects. Although American orthodontists refute the role of functions on facial growth, European practitioners continue to use functional therapeutics.
The publication of the results of studies, on rats and macaques, by Pétro-vic 54, 64 and Mcnamara 31, 45 has revived the debate. They showed the possibility of an increase in mandibular length in these animals.
however, did these data offer any hope that treatment for mandibular retrognathism would be effective? Would it be possible to treat a skeletal Class-II malocclusion with a long-term increase in mandibular length, similar to that of orthognathic surgery? The enthusiasm raised by the publication of these studies was tempered by the level of evidence of studies in animals, classified as being on the lowest level of the pyramid hierarchy of facts 27, 50, 60 ( Fig. 26) , and by the difficulty of a possible transposition of the experimental conditions in humans. It seems difficult to propose the permanent wearing of a hyperpropulsor for the whole duration of the patient's growth, such as with rats and monkeys, on which the studies were conducted. nevertheless, the thought was still firmly anchored that only a first phase of treatment by functional device allowed the orthopedic correction of a Class-II malocclusion, by modifying the direction and amount of mandibular growth.
Since then, although many studies 22, 46, 51, 71 , systematic reviews 20, 52 , and a recent Cochrane systematic review 66 , have shown the possibility of a shortterm increase in mandibular growth, they have also established that the effects of long-term skeletal treatment are weak and insignificant at best (Fig. 27a and b, Fig. 28a-c, Fig. 29 , Fig. 30a-c, Fig. 31a-c, Fig. 32a-c,  Fig. 33a and b, Fig. 34 ).
Figure 26
The hierarchy of facts 27, 50, 60 . a b 
Figure 30 Right vestibular (a), low-angle (b), and left (c) views of the therapeutic setup, totally individualized, directed with an Articulator SAM II, having been used to manufacture the elasticated devices (Laboratoire France Élastodontie ® ). The apparent dental disharmony defect is related to the demand for a slight hypercorrection of a Class I.
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The end of the debate?
It must be noted that the enthusiastic hypothesis of an effective cure for mandibular retrognathism has given way to a false hope, which has been invalidated, publication after publication, by factual data.
Why have we not closed this debate? Why have we not yet completely changed the treatment paradigm? Why are we still talking about a treatment for mandibular retrognathism, and not, simply, a correction of a Class-II malocclusion? Some of the explanations can be found in simple facts: -One is the persistence of the erroneous belief that multiattachment devices, unlike functional devices, can only treat a Class-II malocclusion with dentoalveolar compensation, and possibly by maxillary retraction when the treatment is coupled with the use of an extraoral force; -Another is the apparent stability of Class-II malocclusions, which, if untreated, do not appear to be mitigated by growth 19, 38 . This widespread clinical observation casts doubt on the clinicians' mistaken belief that mandibular growth may make a favorable contribution to Class-II correction. -These facts do not in any way challenge the published data and the aforementioned conclusion of the debate. They are simply explained by the phenomenon of dentoalveolar compensation 42, 63 .
The dentoalveolar compensation phenomenon
Björk and Skieller have shown that, for most patients, mandibular growth is greater than maxillary growth 10 . This maxillofacial growth differential does not depend on the initial Angle Class-it is observed, both in Class-I and Class-II patients 39 . Other authors 9, 34 have confirmed the existence of this differential of maxillomandibular growth differential, which is favorable to the skeletal correction of Class-II malocclusions, whether or not a Class-II treatment is applied.
In a Class-II patient, in the absence of treatment, occlusal meshing and labial-lingual interposition, prevent the excess of mandibular growth from participating in the correction of the Class-II occlusion 8 . This excess mandibular growth leads, in fact, to a mesialization of the maxillary dental arch, giving the clinical illusion that growth has no effect on Class-II patients. This is the phenomenon of dentoalveolar compensation 42, 63 . On average, the maxillary dental arch is mesial by an amount equal to the excess mandibular growth 34 . In a Class-II patient, if functional therapy is applied, the mandible is maintained in Class-I occlusion, while a growth catchup 35 eliminates the occlusion of convenience induced by the therapy. This catching up of growth occurs without any maxillary dentoalveolar compensation 38 . The functional device prevents the maxillary arch from advancing.
In a Class-II patient, if a single-phase multibracket treatment is applied, the belief persists that this treatment cannot improve skeletal shift. In fact, in this case too, the growth of the mandible exceeds that of the maxilla. For example, nine times out of 10 in a study by Johnston LE Jr 36 , who writes that it is necessary to "give Caesar what is Caesar's" and recognize the involvement of the different maxillomandibular growth in the correction of Class-II malocclusions, regardless of the treatment device used.
Which Class-II malocclusion treatment, is most appropriate for a child or adolescent individual?
The daily clinical experience of practitioners shows that the correction of a Class-II shift in children and adolescents can be effectively achieved through a large number of therapeutic modalities. They vary from the use of functional devices 1 , possibly associated with auxiliaries 40 , to orthognathic surgery, including, among others, the distalization of the maxillary arch with the use of extraoral or bone anchors or compensatory extractions.
however, a treatment process, for example the one chosen for the case no. 1 (Fig. 3-9 ), can certainly be effective, but was it the most appropriate? Was it the one which best met our therapeutic objectives and the concerns and preferences of our patient and their family?
Answering this question requires defining individual decision-making factors in the patient's specific case. This description would require development that is inconsistent within the limited scope of this article. Our main current clinical decision-making factors-anatomical, risk, psychosocial and external factors-are grouped together in a diagram (Fig. 35) .
We will limit ourselves to addressing a few clinical issues and cases, which would enable us to illustrate the paradigm shift in the treatment of Class-II malocclusions in children and adolescents.
Maxillary prognathism or mandibular retrognathism: the same treatment?
Even if the disillusion is great, it is necessary to accept the conclusions of the published data 22, 46, 51, 71, 20, 52, 66 . For most children and adolescents with Class-II malocclusions, mandibular growth will be clinically similar, whether or not these patients are treated 7 with functional devices or multiattachments with or without the use of extraoral or bone anchors or compensatory extractions. It does not matter, then, that Class-II malocclusions are mainly dental or skeletal and show signs of maxillary prognathism or mandibular retrognathism, our therapeutic field of action is ultimately almost the same 36 . For example, if a skeletal Class II is related to maxillary prognathism, the use of a functional device (Fig. 36a-c,  Fig. 37a-d, Fig. 38, Fig. 39a-d, Fig.  40a-d, Fig. 41a-c, Fig. 42 ) is as relevant as that of an orthopedic device to inhibit maxillary growth. first maxillary molars, extracted for endodontic reasons), and a Class-II corrector 6 . Case no. 7 (Fig. 43) , less favorable, was treated with a bimaxillary multiattachment and elasticated device. he required the extraction of the second maxillary premolars seconds and the first mandibular premolars, and orthognathic surgery, with an Epker advanced mandible, and a height reduction and projection genioplasty.
This data does not exempt clinicians from the delicate appreciation of the mandibular growth potential 17, 21 and the possible need for orthognathic surgery. What treatment objectives should be given priority?
Abandoning the objective of a perennial increase in mandibular length, allows us to refocus the treatment on the achievement of other therapeutic objectives.
Depending on the individual case of the patient, clinicians may, in particular, aim to decrease the risk of trauma of the maxillary incisors 66 , decrease the risk of root resorptions 62 , improve the quality of life 24 , increase the volume of the airways 32, 58, 68, 70 , and improve any obstructive sleep disorders 14, 30, 65 .
Which treatment device should you choose?
All Class-II treatment devices, including, functional devices, intermaxillary elastics, extraoral forces and temporary bone-anchoring devices, have no 15, 25, 34, 44 , and orthognathic surgery (Epker advanced mandible and genioplasty to decrease the height and projection, performed by Dr. Y. Heuzé).
overall influence, better or worse, on the mandibular growth response. If the choice of one of these devices is therefore neutral in respect to increasing mandibular length, it is not neutral with respect to other elements, such as the risk of the appearance of unstable dentoalveolar compensations. The strength and cost of the device, its ease of implementation, and its acceptance by the patient should also be considered.
It is clearly no longer the case today that clinicians would propose a more restrictive device or a device which is more difficult to implement when trying to find a cure for mandibular retrognathism.
They are now free, when proposing to the patient the various therapeutic approaches, to privilege, with pragmatism and common sense, the other criteria of choice.
With the exception of case 7, treatments in all cases presented in this article involved a first stage of treatment with a functional device, i.e., Class-II corrector 6 . Class-II correctors are preferred for the early stage of treatment (Fig. 44a-c,  Fig. 45, Fig. 46a-c, Fig. 47 ), and also for later treatments, such as those used in case no. 9 ( Fig. 48a and b, Fig. 49a-d,  Fig. 50, Fig. 51a-d, Fig. 52a and b,  Fig. 53 ).
The patient, aged 13 years 5 months, was being transferred from one orthodontic practice to another, following a shift in residence. he had a Class-II, Angle 1 Division 1 malocclusion with a 10-mm overhang on a Class-II skeletal pattern, with mandibular retrognathism, vestibuloversion of the mandibular incisors, and anterior vertebral insufficiency.
he refused surgery, which had been planned by the previous orthodontist, and wanted to stop wearing the multiattachment device. Following the presentation to the patient and their family about the diagnosis, the various treatment options, including the complete cessation of treatment at his request, the benefits and risks of these options, the patient agreed to try treatment with a functional device. he observed the procedure and wore the Class-II corrector 6 for 6 months, put in place after the removal of the multiattachment device. he does not envisage any other treatment if the result obtained remains stable. The future feeds on the past. With his customary humor, J. Philippe wrote how effective orthodontics practiced in the 1960s was 57 . For example, Mrs. Tacail described a mandibular advance of 1 cm as a regression. The subsequent introduction of teleradiography and cephalometric overlay EBO has also been, and is, a source of scientific and clinical progress. To discover that the long-term skeletal effects of a first phase of treatment, are, at best, weak and clinically insignificant 20, 52, 66 , was a bitter disappointment for our profession. But this new data has also enabled a therapeutic evolution, a beneficial paradigm shift toward a more appropriate treatment of Class-II malocclusions to the individual patient case of a child or adolescent.
